News

There have been recent positive steps forward for people with MS considering AHSCT. Read the current thinking towards AHSCT for people with MS.

CEO Rohan Greenland gives an update on the MS Australia activities for October, focusing on the world's largest MS research conference ECTRIMS and the importance of conferences in shaping the future of MS.

In 2015 Sarah's life changed completely when she was diagnosed with multiple sclerosis, she is now on a mission to raise funds to power MS research.

The International Progressive MS Alliance has recently highlighted that very little progress has been made in treating and understanding MS fatigue.

MS Australia's advocacy efforts have contributed to a number of subsidised MS medications and disease-modifying therapies (DMTs). New research now shows the effect this has on the outcomes for people living with MS in New Zealand.

As part of our advocacy work at MS Australia, we make many submissions each year, to various Australian Government inquiries and consultations.

MS Australia President, Associate Professor Desmond Graham has received University of Tasmania’s 2021 Award for Outstanding Contribution.

Over $6.7 million dollars will be invested into MS research by the National Health and Medical Research Council (NHMRC) in their funding scheme.

The Federal Health Minister has announced the listing of Kesimpta® (ofatumumab) on the PBS for the treatment of relapsing remitting MS.

His Excellency General the Honourable David Hurley AC DSC (Retd), the Governor-General of Australia, generously gifted a special medallion to MS Australia to award someone who has contributed to our work in significant way.

Australia’s largest ever Paralympic Games team included three athletes living with multiple sclerosis; Emily Petricola, Carol Cooke and Janine Watson.

The Accessible Product Design Alliance is highlighting the struggle with inaccessible products and packaging, experienced by people living with disability.

New research from the Australian National University (ANU) explores the experiences of people with MS accessing healthcare during the COVID-19 pandemic.

Two months ago Catherine’s life changed completely when she was diagnosed with multiple sclerosis, since then she has raised $2,838 to power MS research.

CEO Rohan Greenland, gives an update on the MS Australia activities for September, focusing on the COVID-19 pandemic and its effect on the MS community.

A recent Australian study examined specific effects of vitamin D on immune cells, towards finding new ways to harness vitamin D for MS therapy.

Simon was first diagnosed with multiple sclerosis in 2003 and has decided to make his own positive difference by leaving a gift in his Will to MS Research.

Australian researchers have investigated the work productivity paths of people living with MS and the factors that influence these paths.